Literature DB >> 29017172

The Emerging Roles of CIB1 in Cancer.

Xianwang Wang1,2,3, Xiaochun Peng1, Xueqing Zhang2, Hanyi Xu1, Chengbiao Lu3, Lian Liu1, Jiaxing Song4, Yingjie Zhang5.   

Abstract

Calcium and integrin-binding protein 1 (CIB1) is an EF-hand calcium binding protein, which is involved in many cellular processes, including calcium signaling, cell survival and proliferation, cell migration, cell adhesion and apoptosis. A number of studies have found that CIB1 is ubiquitously expressed and is related to various human diseases, such as cancer, Alzheimer's disease (AD), cardiac hypertrophy and male infertility. The mechanism of CIB1 in human diseases is still not clear, although multiple functions of CIB1 are modulated by interacting with numerous interacting partners. As a calcium binding protein, the roles of CIB1 in calcium signaling by binding calcium or modulating some key modulators, such as calcineurin, integrin, inositol 1,4,5-trisphosphate receptor (IP3R) and taste 1 receptor member 2 (TAS1R2). The tumor promoting mechanisms of CIB1 have been described in different aspects, including promoting tumor cell cycle and proliferation, inhibiting tumor cell apoptosis, and mediating tumor cell migration and angiogenesis. In addition, multiple functions of CIB1, such as neural development, taste or gustation functions, and virus infection are also elucidated. These recent advances have significantly expanded our understanding of the knowledge of CIB1 and highlighted the potential mechanisms of CIB1 in tumor progression.
© 2017 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  CIB1; Calcium; Cancer; Integrin; Tumor progression

Mesh:

Substances:

Year:  2017        PMID: 29017172     DOI: 10.1159/000481873

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  6 in total

1.  Calcineurin Regulatory Subunit Calcium-Binding Domains Differentially Contribute to Calcineurin Signaling in Saccharomyces cerevisiae.

Authors:  Sean Connolly; Devona Quasi-Woode; Laura Waldron; Christian Eberly; Kerri Waters; Eric M Muller; Tami J Kingsbury
Journal:  Genetics       Date:  2018-05-07       Impact factor: 4.562

2.  Tumor-Infiltrated CD8+ T Cell 10-Gene Signature Related to Clear Cell Renal Cell Carcinoma Prognosis.

Authors:  Jie Wang; Feifan Huang; Jingjie Zhao; Peng Huang; Junhua Tan; Meiying Huang; Ruiying Ma; Yu Xiao; Siyuan He; Zechen Wang; Jiajia Shen; Heming Lu; Lingzhang Meng
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

3.  The human CIB1-EVER1-EVER2 complex governs keratinocyte-intrinsic immunity to β-papillomaviruses.

Authors:  Sarah Jill de Jong; Amandine Créquer; Irina Matos; David Hum; Vignesh Gunasekharan; Lazaro Lorenzo; Fabienne Jabot-Hanin; Elias Imahorn; Andres A Arias; Hassan Vahidnezhad; Leila Youssefian; Janet G Markle; Etienne Patin; Aurelia D'Amico; Claire Q F Wang; Florian Full; Armin Ensser; Tina M Leisner; Leslie V Parise; Matthieu Bouaziz; Nataly Portilla Maya; Xavier Rueda Cadena; Bayaki Saka; Amir Hossein Saeidian; Nessa Aghazadeh; Sirous Zeinali; Peter Itin; James G Krueger; Lou Laimins; Laurent Abel; Elaine Fuchs; Jouni Uitto; Jose Luis Franco; Bettina Burger; Gérard Orth; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2018-08-01       Impact factor: 17.579

Review 4.  IP3R Channels in Male Reproduction.

Authors:  Xiaoning Zhang; Rongzu Huang; Yang Zhou; Wenwen Zhou; Xuhui Zeng
Journal:  Int J Mol Sci       Date:  2020-12-02       Impact factor: 5.923

5.  Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis.

Authors:  Sven Jacob; Florian Bösch; Markus B Schoenberg; Elise Pretzsch; Christopher Lampert; Ren Haoyu; Bernhard W Renz; Marlies Michl; Jörg Kumbrink; Thomas Kirchner; Jens Werner; Martin K Angele; Jens Neumann
Journal:  BMC Cancer       Date:  2021-11-18       Impact factor: 4.430

Review 6.  The Relationship of Sphingosine Kinase 1 With Pyroptosis Provides a New Strategy for Tumor Therapy.

Authors:  Xianwang Wang; Yue Yang; Wen-Qi Cai; Yingying Lu
Journal:  Front Immunol       Date:  2020-10-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.